Effects of nifedipine on endothelial function, assessed by flow-mediated vasodilatation in pregnant patients

References

• Sarri G, Davies M, Gholitabar M, et al. Preterm labour: summary of NICE guidance. BMJ. 2015;351:h6283,
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists, Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 127: management of preterm labor. Obstet Gynecol. 2012;119(6):1308–1317.
   PubMedGoogle Scholar
• ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2011;117(2 Pt 1):422–424.
   PubMedGoogle Scholar
• Papatsonis DN, Van Geijn HP, Dekker GA. Nifedipine as a safe and effective tocolytic agent in the treatment of preterm labor. Am J Obstet Gynecol. 2000;183(2):513–514.
   PubMed Web of Science ®Google Scholar
• Papatsonis DNM, van Geijn HP, Bleker OP, et al. Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int J Gynaecol Obstet. 2003;82(1):5–10.
   PubMed Web of Science ®Google Scholar
• King JF, Flenady V, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;2014(6):CD002255.
   PubMedGoogle Scholar
• Carr DB, Clark AL, Kernek K, et al. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol. 1999;181(4):822–827.
   PubMed Web of Science ®Google Scholar
• Sayin NC, Varol FG, Balkanli-Kaplan P, et al. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor. J Perinat Med. 2004;32(3):220–224.
   PubMed Web of Science ®Google Scholar
• Naik Gaunekar N, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;2013(10):CD004071.
   Google Scholar
• Aggarwal A, Bagga R, Girish B, et al. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome. J Obstet Gynaecol. 2017;38(2):177–184.
   PubMedGoogle Scholar
• van Veen AJ, Pelinck MJ, van Pampus MG, et al. Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG. 2005;112(4):509–510.
   PubMed Web of Science ®Google Scholar
• Ogunyemi D. Risk factors for acute pulmonary edema in preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2007;133(2):143–147.
   PubMed Web of Science ®Google Scholar
• Hodges R, Barkehall-Thomas A, Tippett C. Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG. 2004;111(4):380–381.
   PubMed Web of Science ®Google Scholar
• Bal L, Thierry S, Brocas E, et al. Pulmonary edema induced by calcium-channel blockade for tocolysis. Anesth Analg. 2004;99(3):910–911.
   PubMed Web of Science ®Google Scholar
• Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, et al. Acute pulmonary oedema during nicardipine therapy for premature labour: report of five cases. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):98–99.
   PubMed Web of Science ®Google Scholar
• Philippe H-J, Le Trong A, Pigeau H, et al. Acute pulmonary edema occurred during tocolytic treatment using nicardipine in a twin pregnancy. Report of three cases. J Gynecol Obstet Biol Reprod. 2009;38(1):89–93.
   PubMedGoogle Scholar
• Khan K, Zamora J, Lamont RF, et al. Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis. J Matern Fetal Neonatal Med. 2010;23(9):1030–1038.
   PubMed Web of Science ®Google Scholar
• Yamasato K, Burlingame J, Kaneshiro B. Hemodynamic effects of nifedipine tocolysis. J Obstet Gynaecol Res. 2015;41(1):17–22.
   PubMed Web of Science ®Google Scholar
• Harris RA, Nishiyama SK, Wray DW, et al. Ultrasound assessment of flow-mediated dilation. Hypertension. 2010;55(5):1075–1085.
   PubMed Web of Science ®Google Scholar
• Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J. 1995;74(3):247–253.
   PubMedGoogle Scholar
• Faber-Swensson AP, O'Callaghan SP, Walters WA. Endothelial cell function enhancement in a late normal human pregnancy. Aust N Z J Obstet Gynaecol. 2004;44(6):525–529.
   PubMed Web of Science ®Google Scholar
• Lopes van Balen VA, van Gansewinkel TAG, de Haas S, et al. Physiological adaptation of endothelial function to pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;50(6):697–708.
   PubMed Web of Science ®Google Scholar
• Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363–368.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Paini A, et al. Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens. 2008;26(8):1612–1618.
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs. 2002;62(2):265–284.
   PubMed Web of Science ®Google Scholar
• Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7–17.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Belotti E, et al. Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients. Blood Press. 2011;20(4):244–251.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens. 1996;14(10):1247–1255.
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Magagna A, Versari D, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003;41(6):1281–1286.
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Kametas NA, Donald AE, et al. Non-invasive assessment of endothelial function in normal pregnancy. Ultrasound Obstet Gynecol. 2000;15(6):502–507.
   PubMed Web of Science ®Google Scholar
• Dørup I, Skajaa K, Sørensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol. 1999;276(3):H821–H825.
   PubMedGoogle Scholar
• Porto LB, Brandão AHF, Leite HV, et al. Longitudinal evaluation of uterine perfusion, endothelial function and central blood flow in early onset pre-eclampsia. Pregnancy Hypertens. 2017;10:161–164.
   PubMed Web of Science ®Google Scholar
• Brandão AHF, Cabral MA, Leite HV, et al. Endothelial function, uterine perfusion and central flow in pregnancies complicated by preeclampsia. Arq Bras Cardiol. 2012;99(4):931–935.
   PubMed Web of Science ®Google Scholar
• Grin L, Laish-Farkash A, Shenhav S, et al. Safety of nifedipine in threatened preterm labor: investigation by three-dimensional echocardiography. Echocardiography. 2018;35(8):1164–1170.
   PubMed Web of Science ®Google Scholar
• Namazov A, Grin L, Karakus R, et al. An effect of maternal nifedipine therapy on fetoplacental blood flow: a prospective study. Arch Gynecol Obstet. 2018;298(4):685–688.
   PubMed Web of Science ®Google Scholar
• Cornette J, Duvekot JJ, Roos-Hesselink JW, et al. Maternal and fetal haemodynamic effects of nifedipine in normotensive pregnant women. BJOG. 2011;118(4):510–540.
   PubMed Web of Science ®Google Scholar